cervical cancer Euroimmun to Sell Oncgnostics Cervical Cancer Test in Certain Parts of Europe Oncgnostics also expects the test to be approved by regulators in Canada and to be sold there by the end of the year. Looking Beyond Pandemic, Roche Eyes Growing Opportunities for Dx Testing Premium Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally. Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy The partners will develop a test to identify women most likely to benefit from VGX-3100, Inovio's immunotherapy to treat HPV-associated advanced cervical dysplasia. Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year. Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay The supplement adds a collection vial to the BD Onclarity test and includes performance data for the BD Viper LT and the BD COR Systems. Aug 3, 2020 Cervical Cancer Study in Ugandan Women Finds HPV-Specific Tumor DNA Methylation, Gene Expression Jul 22, 2020 BD Receives FDA Supplemental Premarket Approval for Extended Genotyping HPV MDx Apr 21, 2020 Roche Gets FDA Approval for HPV Test Used With Cobas 6800/8800 Platforms Mar 26, 2020 Cervicovaginal Microbiomes of HPV-Infected Women Lead To Potential Pre-Cancer Marker Jan 30, 2020 Atila Biosystems High-Throughput Isothermal HPV Test Validated in Study Premium Nov 20, 2019 Beckman Coulter, IncellDx Form Cancer Assay Promotion Agreement Nov 12, 2019 Becton Dickinson Submits HPV Assay for Expanded US Premarket Approval Oct 18, 2019 Cervical Cancer Exomes Point to Potentially Targetable HER, PIK3CA Pathway Changes Aug 30, 2019 Transcriptome-Based HPV Assay Shows Correlation With High-Grade Cytology Premium Aug 8, 2019 Atila BioSystems Targets Low-Resource Settings With Rapid, High-Throughput HPV Genotyping System Premium Jul 29, 2019 Startup Credo Biomedical Launching Low-Cost Point-of-Care Influenza MDx Premium Jul 11, 2019 Cancer Detection Firm StageZero Raises C$2.7M Jun 12, 2019 BGI Genomics Continues to Grow Clinical Testing Business, Add Partnerships Premium May 13, 2019 Studies Outline Outcomes Associated With Cervical Cancer Screening, Triage Strategies Feb 26, 2019 Oncgnostics Cervical Cancer Assay Receives Extended CE-IVD Mark Feb 21, 2019 With Studies Underway in South America and Asia, QuantuMDx Readies POC Platform for Launch Premium Feb 20, 2019 Cervical Microbes Potentially Tied to Viral Infections, High-Grade Lesions Feb 19, 2019 Genomica, HuaSin Ink HPV Genotyping Platform Agreement for Chinese Markets Jan 10, 2019 Potential Prognostic Signature Described in HPV-Positive Squamous Cell Carcinomas Nov 2, 2018 Negative HPV DNA Test Result Could Lessen Need for Cervical Cancer Screening Load More Breaking News People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test Yourgene Health Awarded £232K Contract to Supply Oncology Genotyping Testing Kits to NHS Wales Qiagen to Distribute JADBio Life Science Analytics Platform BC Platforms Forms Data Management Alliance With Nonprofit CureDuchenne 23andMe Stock Soars 22 Percent on Closing of Merger With VG Acquisition Corp The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.